The positive reaction to Hinge Health’s initial public offering from Wall Street has brought optimism back to digital health.

Hinge Health leads in digital physiotherapy with strong ROI, sensor-free tech, and major growth potential in public and ...

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health today announced the pricing of its initial public offering of an aggregate ...

US stocks closed higher on Monday (June 2), the first trading session of June, as markets shrugged off mounting global trade ...

Digital therapeutics (DTx) developer Hinge Health has published a new prospectus for an initial public offering (IPO) in the US, shrugging off the weakness in stock markets caused by President ...

Neuralink is building a brain-computer interface, or BCI, which is a system that translates brain signals into commands for ...

marking the second digital health company to go public in 2025, following on the heels of Hinge Health’s public debut last week. It intends to list on the Nasdaq Global Market under the ticker ...

Hinge Health finally goes public after a three-year delay, debuting on the New York Stock Exchange at $32 per share. UnitedHealth Group has been a reliable megacap for years. Its sudden decline in ...

GLP-1 (glucagon-like peptide-1) therapies can be powerful tools in managing obesity, with patients taking these medications ...

In a signal of a return to investor appetite for digital health stocks, Hinge Health has raised an impressive $437 million in an IPO. The importance of biosimilars only continues to grow ...

At Bessemer, Cheatham helped make early investments in health tech companies Abridge and Hinge Health, now multi-billion dollar companies. When asked about his investing thesis, Cheatham said that ...